Insa Inc. Launches First Medical Marijuana Dispensary in Pennsylvania

Insa Inc. has officially opened its first medical marijuana dispensary in Pennsylvania, located at 3511 West Chester Pike in Newtown Square. This new establishment marks a significant milestone for the company, as it expands its operations from cultivation and crafting to direct retail, providing patients with access to premium medical marijuana products.

The Newtown Square dispensary is designed to be an experiential and educational space, offering a diverse range of crafted medical marijuana products. Patients in Pennsylvania can now find a comprehensive selection of Insa’s offerings, including the popular Signature Genetics line, as well as the Gillie Grows by Insa flower collection created in collaboration with Philadelphia’s own Gillie Da King. Additionally, customers can purchase the well-known Insa Troches, further enhancing the variety available in-store.

Patient-Centric Experience

Insa’s Newtown Square location emphasizes comfort and education, aimed at creating a welcoming atmosphere for visitors. The dispensary features a modern layout and is staffed by knowledgeable experts ready to assist patients in finding the products that best suit their needs. This focus on customer service aligns with Insa’s mission to foster connection and support within the community.

Operating hours for the dispensary are 10:00 a.m. to 8:00 p.m. from Monday to Saturday, and 10:00 a.m. to 6:00 p.m. on Sundays. This schedule is designed to accommodate a broad range of patients seeking access to their preferred medical marijuana products.

Insa Inc. has positioned itself as a leader in the medical marijuana sector within Pennsylvania. With this new dispensary, the company aims to make high-quality products more accessible to patients, reinforcing its commitment to health and wellness in the local community. As the market for medical marijuana continues to evolve, Insa’s expansion could play a pivotal role in shaping the landscape of patient care in the state.